How Much Did Gene Matrix Raise?
Funding & Key Investors

Gene Matrix has secured $150K in total capital, with its most recent financing round bringing in $150K. This major strategic investment underscores the company's significant progress and its pivotal role in the evolving landscape of genetic analysis and personalized medicine. The substantial backing positions Gene Matrix for accelerated growth and further innovation in its field.

What is Gene Matrix?

Gene Matrix
Business ServicesResearch & DevelopmentHealthcare Services

Gene Matrix LLC is a pioneering organization dedicated to advancing the field of genetic analysis and personalized medicine. The company's mission is to unlock the potential of genomics to improve healthcare outcomes and enhance the quality of life for individuals worldwide. By leveraging cutting-edge technologies such as next-generation sequencing and AI-driven data analytics, Gene Matrix provides accurate, affordable, and accessible genetic testing solutions. Their innovative approach enables healthcare providers to tailor treatments based on individual genetic profiles, making precision medicine a reality. Gene Matrix is committed to ongoing research and development to stay at the forefront of genomic science and to continuously improve its offerings, while also advocating for ethical standards and patient privacy in genetic testing.

How much funding has Gene Matrix raised?

Gene Matrix has raised a total of $150K across 1 funding round:

2024

Debt

$150K

Debt (2024): $150K with participation from Huntington National Bank

Key Investors in Gene Matrix

Huntington National Bank

Huntington National Bank is a financial institution that provides a range of banking and financial services, likely participating in this funding round through debt financing to support Gene Matrix's operational expansion and strategic initiatives.

What's next for Gene Matrix?

With this significant strategic investment, Gene Matrix is poised to further solidify its market leadership and expand its technological capabilities. The capital infusion will likely fuel advancements in AI-driven data analytics and next-generation sequencing platforms, enhancing the precision and accessibility of their genetic testing solutions. This funding round signals a strong investor confidence in Gene Matrix's vision for personalized medicine, suggesting a trajectory towards broader clinical adoption and potentially new market entries. The company's focus on research and development, coupled with its commitment to ethical practices, positions it for sustained growth and impact in the global healthcare sector.

See full Gene Matrix company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Accounting for Legal PracticesBusiness ServicesProject Management
Accounting for Legal PracticesBusiness Services
Business ServicesTranslation
Business ServicesField Service ManagementConsumer ServicesCleaning Services

Frequently Asked Questions Regarding Gene Matrix Financial Insights

What are the most recent funding rounds that Gene Matrix has completed, and what were the funding rounds?
Gene Matrix has recently completed 1 funding rounds: Debt on Sep 30, 2024.
What is the total amount of funding Gene Matrix has raised to date?
Gene Matrix has raised a total of $150K in funding to date.
How many funding rounds has Gene Matrix completed?
Gene Matrix has completed 1 funding rounds.
How much funding did Gene Matrix raise in its most recent funding round?
Gene Matrix raised $150K in its most recent funding round.
Who are the lead investors in Gene Matrix's latest funding round?
The lead investor in Gene Matrix's latest funding round was Huntington National Bank. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Gene Matrix's history?
The largest funding round in Gene Matrix's history was $150K.
See more information about Gene Matrix